Related Experiment Video
Updated: Feb 27, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases
Nan Hong1, Min Chen1, Wenjie Fang1
1Shanghai Key Laboratory of Molecular Medical Mycology, Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Abstract:
Cryptococcosis is a lethal fungal infection mainly caused by Cryptococcus neoformans/C. gattii species. Currently, our understanding of cryptococcosis episodes in HIV-negative patients during renal dialysis remains scarce and fragmented. Here, we performed an analysis of pooled cases to systemically summarize the epidemiology and clinical characteristics of cryptococcosis among HIV-negative patients with renal dialysis. Using pooled data from our hospital and studies identified in four medical databases, 18 cases were identified and analyzed. The median duration time of renal dialysis for peritoneal renal dialysis and hemodialysis cases was 8 months and 36 months, respectively. Several non-neoformans/gattii species were identified among the renal dialysis recipients with cryptococcosis, particularly Cryptococcus laurentii and Cryptococcus albidus, which share similar clinical manifestations as those caused by C. neoformans and C. gattii. Our analyses suggest that physicians should consider the possibility of the occurrence of cryptococcosis among renal dialysis recipients even when cryptococcal antigen test result is negative. The timely removal of the catheter is crucial for peritoneal dialysis patients with cryptococcosis. In addition, there is a need for optimized antifungal treatment strategy in renal dialysis recipients with cryptococcal infections.
Insights
Cryptococcosis in HIV-negative dialysis patients is poorly understood. This study highlights non-neoformans/gattii species and suggests considering cryptococcosis even with negative antigen tests, emphasizing catheter removal and optimized antifungal strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Nephrology
Background:
- Cryptococcosis, a serious fungal infection, is primarily caused by Cryptococcus neoformans/C. gattii.
- Data on cryptococcosis in HIV-negative patients undergoing renal dialysis is limited.
- Understanding this infection in dialysis patients is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To systematically review the epidemiology and clinical features of cryptococcosis in HIV-negative patients on renal dialysis.
- To pool data from multiple sources to increase statistical power and provide a comprehensive overview.
- To identify specific challenges and recommendations for managing cryptococcosis in this vulnerable population.
Main Methods:
- A pooled analysis of 18 cases from the authors' hospital and four medical databases.
- Analysis of epidemiological data, including dialysis modality and duration.
- Review of clinical manifestations and causative fungal species.
Main Results:
- The median dialysis duration was 8 months for peritoneal dialysis and 36 months for hemodialysis.
- Non-neoformans/gattii species, such as Cryptococcus laurentii and Cryptococcus albidus, were identified.
- Clinical presentations of these non-neoformans/gattii species were similar to those of C. neoformans and C. gattii.
Conclusions:
- Physicians should suspect cryptococcosis in renal dialysis patients, even with negative cryptococcal antigen tests.
- Prompt catheter removal is vital for peritoneal dialysis patients diagnosed with cryptococcosis.
- Optimized antifungal treatment strategies are needed for renal dialysis recipients with cryptococcal infections.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
06:27A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Related Concept Videos
Retrovirus Life Cycles
Chronic Kidney Disease II: Clinical Manifestations
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Kidney Injury IV: Diagnostic Studies and Prevention